Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies

PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies

US Patent 7550269 · Granted Jun 23, 2009

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Circulating ESM-1 (endocan) in the assessment of atrial fibrillation and/or stro2025
Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fi2023
Assessing whether a subject shall be subjected to imaging based diagnostic2022
Anti-human migration stimulating factor (MSF) and uses thereof2022
Biomarkers for risk prediction of mortality2020
Diagnostic test for inflammatory endothelial dysfunctions in pregnancies2015
Permanent magnet rotor for a rotary electric machine2015
Methods of making an antibody that binds a chemerin polypeptide2011
Pharmaceutical compositions containing the long pentraxin PTX32011
Nucleic acids encoding ChemerinR ligands2011
Monoclonal antibodies, hybridomas, improved method for determining the protein P2011
Use of the long pentraxin PTX3 for the treatment of diseases caused by an altere2010